PCI Pharma Services operates across the full development and commercialization spectrum for pharmaceutical and healthcare companies. The firm provides drug development, manufacturing, clinical trial services, advanced drug delivery systems and packaging solutions designed to accelerate time-to-market whilst maintaining quality standards integrated from inception.
The company operates 38 facilities across North America, Canada, the United Kingdom, Ireland, Germany, Spain and Australia, employing over 8,500 personnel. It supports more than 90 product launches annually and brings over 50 years of healthcare sector experience to its work. PCI integrates quality management, supply-chain integration and sustainability into its service delivery, with emissions reduction goals validated by the Science Based Targets initiative.
Its service offerings span the pharmaceutical lifecycle: from early-stage development through manufacturing scale-up, clinical supply chain support, and final packaging and commercialization. The company positions itself as an extension of customers' value chains rather than a standalone vendor, embedding quality assurance and operational continuity as core principles.
